Automation Improves Tobacco Research
News Apr 09, 2009
Advanced Technologies Cambridge (ATC) in Cambridge, UK, is using Quantitative PCR techniques to assay transgenic plant cells, and uses Tecan’s Freedom EVO® 100 liquid handling workstation to automate pipetting tasks for these screens. The Company has a strong research interest in plant biotechnology.
Tim Beddoes, a molecular biologist at ATC, explained: “There are a number of toxicants in cigarette smoke with the potential to cause disease, and our aim is to find ways to alter pathways within the tobacco plant that are responsible for those compounds or their precursors. As part of this project, transgenic plants are created and we use Q PCR techniques to assay for introduced sequences. These screens require a lot of pipetting, which we used to perform manually, and with automation we can now run several thousand assays per month.”
“Our current workstation set-up has an eight channel arm and uses Tecan’s 50 µl disposable tips with 384-well format plates. The reproducibility is comparable to manual pipetting, but the tasks are performed much more quickly. We perform our QPCR in final reaction volumes of 25 µl, because using relatively small volumes obviously cuts down on reagent and sample costs, and the 50 µl tips are perfect for pipetting the 5 µl of DNA and 20 µl of master mix. The 50 µl tip is also ideal for aliquoting fractions for experimental replicates.” Tim concluded.
CRISPR Reveals New Targets for Promising Cancer DrugsNews
Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.READ MORE
Cell Recycling System Offers Therapeutic Entry Point for Rare Disease TreatmentNews
Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).READ MORE
Big-Data Analysis Points Toward New Drug Discovery MethodNews
A research team has developed a computational method to systematically probe massive amounts of open-access data to discover new ways to use drugs, including some that have already been approved for other uses.
Comments | 0 ADD COMMENT
EMBL Course: Next Generation Sequencing: RNA Sequencing Library Preparation
Apr 23 - Apr 27, 2018
EMBO Practical Course: Microbial Metagenomics: A 360º Approach
Apr 23 - Apr 30, 2018
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018